Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Suven Life Sciences Ltd (SUVP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
105.50 -0.75    -0.71%
09:40:00 - Real-time Data. Currency in INR ( Disclaimer )
  • Volume: 106,052
  • Bid/Ask: 105.50 / 105.80
  • Day's Range: 102.45 - 106.65
Type:  Equity
Market:  India
ISIN:  INE495B01038 
S/N:  SUVEN
Suven Life Sciences Ltd 105.50 -0.75 -0.71%

Suven Life Sciences Ltd Company Profile

 
Read the Suven Life Sciences Ltd company profile to learn more about the business and the management team. View Suven Life Sciences Ltd facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

117

Equity Type

ORD

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and Ropanicant (SUVN-911), a novel, potent, and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing Usmarapride (SUVN-D4010), a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

Contact Information

Address 8-2-334, SDE Serene Chambers 6th Floor
Road No.5, Avenue 7 Banjara Hills Hyderabad,500034
India
Phone 91 40 2354 1142
Fax 91 40 2354 1152

Top Executives

Name Age Since Title
Sudharani Jasti 68 1989 Whole-Time Director
Venkateswarlu Jasti 73 1989 Executive Chairman & CEO
Seyed Ehtesham Hasnain 70 2010 Non-Independent & Non-Executive Director
Santanu Mukherjee 68 2018 Independent Non-Executive Director
Vajja Sambasiva Rao 70 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SUVP Price Commentary

Write your thoughts about Suven Life Sciences Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
RAJKUMAR KOTTALA
RAJKUMAR KOTTALA Jan 21, 2020 7:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Y price reduced to 15 from 301. Is there any reason for this.
Darshan Gandhi
Darshan Gandhi Aug 14, 2018 9:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy now for a target of 285 for short term and 400 for long term
Sunny Makhija
Sunny Makhija Nov 01, 2017 17:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nakli share
Sunny Makhija
Sunny Makhija Nov 01, 2017 17:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email